Literature DB >> 25385801

Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals.

Cynthia Calzas1, Paul Lemire1, Gael Auray1, Volker Gerdts2, Marcelo Gottschalk1, Mariela Segura3.   

Abstract

Streptococcus suis serotype 2 is an extracellular encapsulated bacterium that causes severe septicemia and meningitis in swine and humans. Albeit crucial in the fight against encapsulated bacteria, the nature of the capsular polysaccharide (CPS)-specific antibody (Ab) response during S. suis type 2 infection is unknown. We compared for the first time the features of CPS-specific versus protein-specific Ab responses during experimental infections with live virulent S. suis type 2 in mice. The primary protein-specific Ab response was dominated by both type 1 and 2 IgG subclasses, whereas IgM titers were more modest. The secondary protein-specific Ab response showed all of the features of a memory response with faster kinetics and boosted the titers of all Ig isotypes. In contrast, the primary CPS-specific Ab response was either inexistent or had titers only slightly higher than those in noninfected animals and was essentially composed of IgM. A poor CPS-specific memory response was observed, with only a moderate boost in IgM titers and no IgG. Both protein- and CPS-specific Ab responses were Toll-like receptor 2 independent. By using S. suis type 2 strains of European or North American origin, the poor CPS-specific Ab response was demonstrated to be independent of the genotypic/phenotypic diversity of the strain within serotype 2. Finally, the CPS-specific Ab response was also impaired and lacked isotype switching in S. suis-infected pigs, the natural host of the bacterium. The better resistance of preinfected animals to reinfection with the same strain of S. suis type 2 might thus more likely be related to the development of a protein rather than CPS Ab response.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25385801      PMCID: PMC4288899          DOI: 10.1128/IAI.02427-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  72 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  The role of toll-like receptors in the pathogenesis of Streptococcus suis.

Authors:  Han Zheng; Xia Luo; Mariela Segura; Hui Sun; Changyun Ye; Marcelo Gottschalk; Jianguo Xu
Journal:  Vet Microbiol       Date:  2011-10-19       Impact factor: 3.293

Review 3.  Streptococcus suis: a new emerging or an old neglected zoonotic pathogen?

Authors:  Marcelo Gottschalk; Jianguo Xu; Cynthia Calzas; Mariela Segura
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

4.  Passive immunization of pigs against experimental infection with Streptococcus suis serotype 2.

Authors:  L O Andresen; C Tegtmeier
Journal:  Vet Microbiol       Date:  2001-08-20       Impact factor: 3.293

5.  Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells.

Authors:  Marie-Pier Lecours; Marcelo Gottschalk; Mathieu Houde; Paul Lemire; Nahuel Fittipaldi; Mariela Segura
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

6.  Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages.

Authors:  M A Segura; P Cléroux; M Gottschalk
Journal:  FEMS Immunol Med Microbiol       Date:  1998-07

Review 7.  How bacterial carbohydrates influence the adaptive immune system.

Authors:  Fikri Y Avci; Dennis L Kasper
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

8.  Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection.

Authors:  María de la Cruz Domínguez-Punaro; Mariela Segura; Danuta Radzioch; Serge Rivest; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

9.  Studies of the protective effect of different fractions of sera from pigs immune to Streptococcus suis type 2 infection.

Authors:  M E Holt; M R Enright; T J Alexander
Journal:  J Comp Pathol       Date:  1989-05       Impact factor: 1.311

10.  Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Authors:  Aaron F Carlin; Satoshi Uchiyama; Yung-Chi Chang; Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

View more
  12 in total

1.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

2.  Recruitment of Factor H to the Streptococcus suis Cell Surface is Multifactorial.

Authors:  David Roy; Daniel Grenier; Mariela Segura; Annabelle Mathieu-Denoncourt; Marcelo Gottschalk
Journal:  Pathogens       Date:  2016-07-07

3.  Immunization with Streptococcus suis bacterin plus recombinant Sao protein in sows conveys passive immunity to their piglets.

Authors:  Kai-Jen Hsueh; Li-Ting Cheng; Jai-Wei Lee; Yao-Chi Chung; Wen-Bin Chung; Chun-Yen Chu
Journal:  BMC Vet Res       Date:  2017-01-07       Impact factor: 2.741

4.  Natural Killer Cell Functions during the Innate Immune Response to Pathogenic Streptococci.

Authors:  Paul Lemire; Tristan Galbas; Jacques Thibodeau; Mariela Segura
Journal:  Front Microbiol       Date:  2017-06-29       Impact factor: 5.640

5.  Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response.

Authors:  Cynthia Calzas; Morgan Taillardet; Insaf Salem Fourati; David Roy; Marcelo Gottschalk; Hugo Soudeyns; Thierry Defrance; Mariela Segura
Journal:  Pathogens       Date:  2017-04-20

6.  Use of Proteins Identified through a Functional Genomic Screen To Develop a Protein Subunit Vaccine That Provides Significant Protection against Virulent Streptococcus suis in Pigs.

Authors:  Susan L Brockmeier; Crystal L Loving; Tracy L Nicholson; Jinhong Wang; Sarah E Peters; Lucy Weinert; Roy Chaudhuri; David J Seilly; Paul R Langford; Andrew Rycroft; Brendan W Wren; Duncan J Maskell; Alexander W Tucker
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

7.  Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax®23.

Authors:  Alena Roth; Stephanie Glaesener; Katharina Schütz; Almut Meyer-Bahlburg
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

8.  Streptococcus suis Serotype 2 Infection Impairs Interleukin-12 Production and the MHC-II-Restricted Antigen Presentation Capacity of Dendritic Cells.

Authors:  Corinne Letendre; Jean-Philippe Auger; Paul Lemire; Tristan Galbas; Marcelo Gottschalk; Jacques Thibodeau; Mariela Segura
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

9.  Characterization and Protective Activity of Monoclonal Antibodies Directed against Streptococcus suis Serotype 2 Capsular Polysaccharide Obtained Using a Glycoconjugate.

Authors:  Guillaume Goyette-Desjardins; Sonia Lacouture; Jean-Philippe Auger; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Pathogens       Date:  2019-09-07

10.  Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from Streptococcus suis Serotypes 3, 7, 8, and 9: the Serotype 3 Polysaccharide Induces an Opsonizing IgG Response.

Authors:  Guillaume Goyette-Desjardins; Jean-Philippe Auger; Dominic Dolbec; Evgeny Vinogradov; Masatoshi Okura; Daisuke Takamatsu; Marie-Rose Van Calsteren; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.